# Development and Evaluation of Ultrasound Image Learning Pipelines for MASLD Risk Stratification

arXiv: https://arxiv.org/abs/2609.04390 · HTML: https://mlsanity.com/paper/2609.04390/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 9 of its 28 references that are in the map.
- First posted on arXiv 3 Sep 2026.

## Builds on (most cited first, 9 of 9)

- [Deep Residual Learning for Image Recognition](https://mlsanity.com/paper/1512.03385/) (2015)
- [An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale](https://mlsanity.com/paper/2010.11929/) (2020)
- [Swin Transformer: Hierarchical Vision Transformer using Shifted Windows](https://mlsanity.com/paper/2103.14030/) (2021)
- [EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks](https://mlsanity.com/paper/1905.11946/) (2019)
- [Delving Deep into Rectifiers: Surpassing Human-Level Performance on ImageNet Classification](https://mlsanity.com/paper/1502.01852/) (2015)
- [A ConvNet for the 2020s](https://mlsanity.com/paper/2201.03545/) (2022)
- [BEiT: BERT Pre-Training of Image Transformers](https://mlsanity.com/paper/2106.08254/) (2021)
- [MaxViT: Multi-Axis Vision Transformer](https://mlsanity.com/paper/2204.01697/) (2022)
- [MambaOut: Do We Really Need Mamba for Vision?](https://mlsanity.com/paper/2405.07992/) (2024)

## Abstract (arXiv)

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of the general population. Ultrasound-based imaging, including B-mode imaging and shear wave elastography (SWE), is widely used for noninvasive fibrosis assessment; however, the role of deep learning-based ultrasound image learning for MASLD risk stratification remains insufficiently characterized. In this study, we developed and evaluated ultrasound image learning pipelines using B-mode and SWE images for fibrosis staging and identification of patients with at-risk metabolic dysfunction-associated steatohepatitis (MASH). A total of 250 ultrasound examinations, one exam per subject, were included. Model performance was evaluated using 3-fold cross-validation with area under the receiver operating characteristic curve (AUROC). End-to-end SWE image learning achieved performance comparable to operator-guided SWE across fibrosis stages. Overall, SWE-based learning consistently outperformed B-mode image learning in fibrosis staging, with AUROC improvements from 0.64 (95%CI: [0.56, 0.72]) to 0.72 (95% CI: [0.65, 0.79]) for F>=2 (significant fibrosis, p=0.11), from 0.67 (95%CI: [0.58, 0.75]) to 0.78 (95% CI:[0.72, 0.85]) for F>=3 (advanced fibrosis, p=0.02), and from 0.69 (95%CI: [0.56, 0.82]) to 0.80 (95%CI: [0.72, 0.89]) for F4 (cirrhosis, p=0.10). These findings highlight the potential of SWE image learning for MASLD risk stratification.